By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Myriad Genetics reported after the close of the market Tuesday that its second-quarter 2012 revenues increased 22 percent year over year with molecular diagnostic revenues up 17 percent.

The Salt Lake City-based firm had total revenues of $122.8 million for the three-month period ended Dec. 31, 2011, compared to $100.4 million for the second quarter of 2011. It beat Wall Street's consensus estimate for revenues of $115.3 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Two new Reproducibility Project: Cancer Biology studies have largely reproduced the original findings, ScienceInsider reports.

DNA fingerprinting could catch some sample mix-ups at pathology labs, the New York Times says.

A Maryland police department has turned to DNA phenotyping to develop a suspect sketch, WJLA reports.

In Cell this week: DNA methylation and T cell exhaustion, longevity in C. elegans, and more.